跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
Clinical significance of p53 mutations in nonhodgkin's lymphoma
P. M. Chen
*
, T. J. Chiou, R. K. Hsieh, C. H. Tzeog, J. H. Liu, F. S. Fan
*
此作品的通信作者
生物藥學研究所
研究成果
:
Article
›
同行評審
總覽
指紋
指紋
深入研究「Clinical significance of p53 mutations in nonhodgkin's lymphoma」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Clinical Significance
100%
TP53 mutation
100%
Non-Hodgkin Lymphoma
100%
Gene Rearrangement
100%
P53 Gene
80%
Point mutation
60%
Gene Alteration
60%
Complete Remission
40%
Mixed Cell
40%
Western Countries
20%
Poor Prognosis
20%
In(III)
20%
Chemotherapy
20%
Poor Survival
20%
MYC Gene
20%
Tumor Suppressor Gene
20%
Clinical Features
20%
P53 Protein Expression
20%
MYC Oncogene
20%
Southern Blot
20%
Single Strain
20%
DNA Rearrangement
20%
Leukemogenesis
20%
Polymorphism Analysis
20%
B-cell non-Hodgkin Lymphoma (B-NHL)
20%
Intermediate Grade
20%
Medicine and Dentistry
Clinical Significance
100%
Protein P53
100%
Non-Hodgkin Lymphoma
100%
Gene Rearrangement
55%
Gene Mutation
33%
Point Mutation
33%
Large Cell
22%
Oncogene C Myc
22%
Clinical Feature
11%
Protein Expression
11%
B Cell
11%
Southern Blotting
11%
Tumor Suppressor Gene
11%
Spontaneous Remission
11%
Leukemogenesis
11%
DNA Determination
11%
Small Cleaved Cells
11%
Blotting
11%
Chemotherapy
11%
Biochemistry, Genetics and Molecular Biology
P53
100%
Gene Rearrangement
100%
Protein P53
80%
Point Mutation
60%
Gene Mutation
60%
Oncogene C Myc
40%
Conformation
20%
Protein Expression
20%
Tumor Suppressor Gene
20%
B Cell
20%
Southern Blotting
20%
DNA Rearrangement
20%
Immunology and Microbiology
P53
100%
Gene Rearrangement
55%
Gene Mutation
33%
Point Mutation
33%
Oncogene C Myc
22%
B Cell
11%
Conformation
11%
Tumor Suppressor Gene
11%
Protein Expression
11%
Southern Blotting
11%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Nonhodgkin Lymphoma
100%
Remission
22%
Chemotherapy
11%
Clinical Feature
11%
Tumor Suppressor Protein
11%
Leukemogenesis
11%